Lavina Bharwani

Cross-Talk between Estrogen Receptor and Growth Factor Pathways as a Molecular Target for Overcoming Endocrine Resistance

Rachel Schiff, Suleiman Massarweh, Jiang Shou et al. · Clinical Cancer Research · 2004 · 465 citations

Medicine, Endocrinology, Oncology +14

Treatment of Human Epidermal Growth Factor Receptor 2-Overexpressing Breast Cancer Xenografts With Multiagent HER-Targeted Therapy

Grazia Arpino, Carolina Gutiérrez, Helen A. Weiss et al. · JNCI Journal of the National Cancer Institute · 2007 · 189 citations · Full text

Medicine, Oncology, Pharmacology +17

Microvesicle‐associated tissue factor and Trousseau's syndrome

Ian Del Conde, Lavina Bharwani, Dennis J. Dietzen et al. · Journal of Thrombosis and Haemostasis · 2006 · 100 citations

Medicine, Pathobiology, Pathology +5

Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive Cancers

Soo Chin Lee, Noriko Shimasaki, Joline S.J. Lim et al. · Clinical Cancer Research · 2020 · 67 citations · Full text

Life Sciences, Immunology, Oncology +17

Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma

Akash Verma, Akhil Chopra, Yeo W. Lee et al. · Current Drug Discovery Technologies · 2016 · 22 citations · Full text

Medicine, Oncology, Pharmacology +15